Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma Limited has informed the NSE about the schedule of an upcoming board meeting. This is a standard regulatory disclosure required under SEBI's Listing Obligations and Disclosure Requirements (LODR). The specific agenda, date, and items to be discussed are not detailed in the headline. Typically, such meetings are convened to consider and approve matters such as financial results, dividends, fundraising, or other significant business decisions.
Neutral in the short term — this is a routine compliance filing and does not by itself indicate any positive or negative development. Shareholders should watch for the detailed outcome of the meeting for any actionable information.